An ERCC4 regulatory variant predicts grade‐3 or ‐4 toxicities in patients with advanced non‐small cell lung cancer treated by platinum‐based therapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0215|142|6|1218-1229

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.142, Iss.6, 2018-03, pp. : 1218-1229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract